Skip to main content

Advertisement

SpringerLink
Log in

Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis

  • Original Contribution
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

An Invited Editorial to this article was published on 04 September 2013

Abstract

Ischaemic preconditioning is one of the most potent experimental modalities known to decrease infarct size after ischaemia and reperfusion. Much interest has been stimulated by the phenomenon of remote ischaemic conditioning (RIC), in which the preconditioning stimulus is applied to a limb remote from the heart to stimulate cardioprotection via an unidentified humoral factor, believed to be a protein between 3.5 and 15 kDa. Stromal cell-derived factor-1 (SDF-1α or CXCL12) is a chemokine of 10 kDa that is induced by hypoxia and recruits stem cells, but also exerts direct, acute, cardioprotection via its receptor, CXCR4. The serum dipeptidase DPPIV cleaves and inactivates SDF-1α. We measured SDF-1α in rat plasma and found it was significantly increased by RIC. DPPIV activity was unchanged after RIC, suggesting that increased synthesis or release or SDF-1α caused the increase in plasma levels. AMD3100, a highly specific inhibitor of CXCR4, was used to investigate the hypothesis that SDF-1α is involved in RIC. RIC in rats, which decreased infarct size from 53 ± 3 % to 27 ± 3 % (n = 6, P < 0.05), was blocked in rats treated with AMD3100 (40 ± 4 %). RIC also improved functional recovery of cardiac papillary muscle, and this, too, was blocked by AMD3100. Direct application of SDF-1α was confirmed to be protective in this model and was blocked by AMD3100. RIC stimulates SDF-1α release, and this 10-kDa peptide appears to be required for the mechanism of RIC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

RIC:

Remote ischaemic preconditioning

SDF-1α:

Stromal cell-derived factor-1 alpha

CXCR:

C-X-C chemokine receptor

DPPIV:

Dipeptidase IV

References

  1. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300–3305. doi:10.1161/01.CIR.0000147780.30124.CF

    Article  PubMed  Google Scholar 

  2. Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, Cremer J, Zacharowski K, Meybohm P (2013) Remote ischemic preconditioning regulates HIF-1alpha levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol 108:314. doi:10.1007/s00395-012-0314-0

    Article  PubMed  Google Scholar 

  3. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727–734. doi:10.1016/S0140-6736(09)62001-8

    Article  PubMed  Google Scholar 

  4. Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK (2011) Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 106:135–145. doi:10.1007/s00395-010-0133-0

    Article  PubMed  CAS  Google Scholar 

  5. Cai ZP, Parajuli N, Zheng X, Becker L (2012) Remote ischemic preconditioning confers late protection against myocardial ischemia–reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 107:277. doi:10.1007/s00395-012-0277-1

    Article  PubMed  Google Scholar 

  6. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858–864. doi:10.1038/nm1075

    Article  PubMed  CAS  Google Scholar 

  7. Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG, Kong D (2008) Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16:571–579. doi:10.1038/sj.mt.6300374

    Article  PubMed  CAS  Google Scholar 

  8. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN (2006) Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47:2277–2282. doi:10.1016/j.jacc.2006.01.066

    Article  PubMed  Google Scholar 

  9. Davidson SM, Hausenloy D, Duchen MR, Yellon DM (2006) Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 38:414–419. doi:10.1016/j.biocel.2005.09.017

    Article  PubMed  CAS  Google Scholar 

  10. De Clercq E (2003) The bicyclam AMD3100 story. Nat Rev Drug Discov 2:581–587. doi:10.1038/nrd1134

    Article  PubMed  Google Scholar 

  11. Dickson EW, Porcaro WA, Fenton RA, Heard SO, Reindhardt CP, Renzi FP, Przyklenk K (2000) “Preconditioning at a distance” in the isolated rabbit heart. Acad Emerg Med 7:311–317. doi:10.1111/j.1553-2712.2000.tb02228.x

    Article  PubMed  CAS  Google Scholar 

  12. Ghadge SK, Muhlstedt S, Ozcelik C, Bader M (2011) SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 129:97–108. doi:10.1016/j.pharmthera.2010.09.011

    Article  PubMed  CAS  Google Scholar 

  13. Hatse S, Princen K, Bridger G, De Clercq E, Schols D (2002) Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527:255–262. doi:10.1016/S0014-5793(02)03143-5

    Article  PubMed  CAS  Google Scholar 

  14. Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14:893–907. doi:10.1089/ars.2010.3360

    Article  PubMed  CAS  Google Scholar 

  15. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di SC, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370:575–579. doi:10.1016/S0140-6736(07)61296-3

    Article  PubMed  Google Scholar 

  16. Hausenloy DJ, Yellon DM (2008) Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 79:377–386. doi:10.1093/cvr/cvn114

    Article  PubMed  CAS  Google Scholar 

  17. Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8:619–629. doi:10.1038/nrcardio.2011.85

    Article  PubMed  CAS  Google Scholar 

  18. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166–175. doi:10.1016/S0140-6736(12)60916-7

    Article  PubMed  Google Scholar 

  19. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M (2012) STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 110:111–115. doi:10.1161/CIRCRESAHA.111.259556

    Article  PubMed  CAS  Google Scholar 

  20. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O’Sullivan M, Dutka DP (2009) Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation 119:820–827. doi:10.1161/CIRCULATIONAHA.108.809723

    Article  PubMed  Google Scholar 

  21. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116:654–663. doi:10.1161/circulationaha.106.672451

    Article  PubMed  CAS  Google Scholar 

  22. Huang C, Gu H, Zhang W, Manukyan MC, Shou W, Wang M (2011) SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 301:H1496–H1505. doi:10.1152/ajpheart.00365.2011

    Article  PubMed  CAS  Google Scholar 

  23. Jensen RV, Stottrup NB, Kristiansen SB, Botker HE (2012) Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Basic Res Cardiol 107:285. doi:10.1007/s00395-012-0285-1

    Article  PubMed  Google Scholar 

  24. Jiang Q, Song P, Wang E, Li J, Hu S, Zhang H (2013) Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. J Mol Cell Cardiol 56:1–7. doi:10.1016/j.yjmcc.2012.12.016

    Article  PubMed  CAS  Google Scholar 

  25. Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, Heveker N (2009) AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75:1240–1247. doi:10.1124/mol.108.053389

    Article  PubMed  CAS  Google Scholar 

  26. Kamota T, Li TS, Morikage N, Murakami M, Ohshima M, Kubo M, Kobayashi T, Mikamo A, Ikeda Y, Matsuzaki M, Hamano K (2009) Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 53:1814–1822. doi:10.1016/j.jacc.2009.02.015

    Article  PubMed  CAS  Google Scholar 

  27. Kanki S, Segers VF, Wu W, Kakkar R, Gannon J, Sys SU, Sandrasagra A, Lee RT (2011) Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 4:509–518. doi:10.1161/CIRCHEARTFAILURE.110.960302

    Article  PubMed  CAS  Google Scholar 

  28. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106:2881–2883. doi:10.1161/01.CIR.0000043806.51912.9B

    Article  PubMed  CAS  Google Scholar 

  29. Kleinbongard P, Thielmann M, Jakob H, Peters J, Heusch G, Kottenberg E (2013) Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther 29(27):359–361. doi:10.1007/s10557-013-6451-3

    Article  Google Scholar 

  30. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J (2012) Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol—a clinical trial. Acta Anaesthesiol Scand 56:30–38. doi:10.1111/j.1399-6576.2011.02585.x

    Article  PubMed  CAS  Google Scholar 

  31. Misra P, Lebeche D, Ly H, Schwarzkopf M, Diaz G, Hajjar RJ, Schecter AD, Frangioni JV (2008) Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J Nucl Med 49:963–969. doi:10.2967/jnumed.107.050054

    Article  PubMed  CAS  Google Scholar 

  32. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R (2010) Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87:406–423. doi:10.1093/cvr/cvq129

    Article  PubMed  CAS  Google Scholar 

  33. Sandhu R, Diaz RJ, Wilson GJ (1993) Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models. Cardiovasc Res 27:602–607

    Article  PubMed  CAS  Google Scholar 

  34. Sasaki T, Fukazawa R, Ogawa S, Kanno S, Nitta T, Ochi M, Shimizu K (2007) Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice. Pediatr Int 49:966–971. doi:10.1111/j.1442-200X.2007.02491.x

    Article  PubMed  Google Scholar 

  35. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, DiMaio JM, Srivastava D (2008) Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117:2224–2231. doi:10.1161/circulationaha.107.694992

    Article  PubMed  CAS  Google Scholar 

  36. Segret A, Rucker-Martin C, Pavoine C, Flavigny J, Deroubaix E, Chatel MA, Lombet A, Renaud JF (2007) Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes. J Histochem Cytochem 55:141–150. doi:10.1369/jhc.6A7050.2006

    Article  PubMed  CAS  Google Scholar 

  37. Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH (2007) Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol 49:214–220. doi:10.1097/FJC.0b013e3180325ad9

    Article  PubMed  CAS  Google Scholar 

  38. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, Redington AN (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci 117:191–200. doi:10.1042/CS20080523

    Article  PubMed  CAS  Google Scholar 

  39. Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM, Hausenloy DJ, Yellon DM (2011) Failure of the adipocytokine, resistin, to protect the heart from ischemia–reperfusion injury. J Cardiovasc Pharmacol Ther 16:63–71. doi:10.1177/1074248410382232

    Article  PubMed  CAS  Google Scholar 

  40. Takahashi M (2010) Role of the SDF-1/CXCR4 system in myocardial infarction. Circ J 74:418–423. doi:10.1253/circj.CJ-09-1021

    Article  PubMed  CAS  Google Scholar 

  41. Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D, Furber A, Prunier F (2011) RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 106:1329–1339. doi:10.1007/s00395-011-0210-z

    Article  PubMed  CAS  Google Scholar 

  42. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104:1209–1216. doi:10.1161/CIRCRESAHA.109.197723

    Article  PubMed  CAS  Google Scholar 

  43. Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J, Jakob H, Heusch G (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105:657–664. doi:10.1007/s00395-010-0104-5

    Article  PubMed  CAS  Google Scholar 

  44. Wong D, Korz W (2008) Translating an antagonist of chemokine receptor CXCR4: from bench to bedside. Clin Cancer Res 14:7975–7980. doi:10.1158/1078-0432.CCR-07-4846

    Article  PubMed  CAS  Google Scholar 

  45. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357:1121–1135. doi:10.1056/NEJMra071667

    Article  PubMed  CAS  Google Scholar 

  46. Zaruba MM, Franz WM (2010) Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opin Biol Ther 10:321–335. doi:10.1517/14712590903460286

    Article  PubMed  CAS  Google Scholar 

  47. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, Fischer R, Krieg L, Hirsch E, Huber B, Nathan P, Israel L, Imhof A, Herbach N, Assmann G, Wanke R, Mueller-Hoecker J, Steinbeck G, Franz WM (2009) Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4:313–323. doi:10.1016/j.stem.2009.02.013

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was funded by the Rosetrees Trust and the British Heart Foundation [RG/08/015/26411]. This work was undertaken at UCLH/UCL who received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme of which DM Yellon is a senior investigator.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK

    Sean M. Davidson, Pradeep Selvaraj, David He, Claire Boi-Doku, Robert L. Yellon, Jose M. Vicencio & Derek M. Yellon

Authors
  1. Sean M. Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pradeep Selvaraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claire Boi-Doku
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert L. Yellon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jose M. Vicencio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Derek M. Yellon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Derek M. Yellon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davidson, S.M., Selvaraj, P., He, D. et al. Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol 108, 377 (2013). https://doi.org/10.1007/s00395-013-0377-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00395-013-0377-6

Keywords

Search

Navigation